On November 7, 2019 Caris Life Sciences, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, reported that Brian J. Brille, Vice Chairman of the Company, will present at two upcoming investor healthcare conferences in New York City (Press release, Caris Life Sciences, NOV 7, 2019, View Source [SID1234550705]). Presentation details are as follows:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Stifel 2019 Healthcare Conference
Wednesday, November 20, 2019, at 10:20 a.m. Eastern Time,
Lotte New York Palace Hotel, Winslow Room
Canaccord Genuity Group 2019 Medical Technologies & Diagnostics Forum
Thursday, November 21, 2019, at 11:00 a.m. Eastern Time,
The Westin Grand Central, Ambassador Room
Mr. Brille will provide an overview of Caris’ business at the conferences and discuss recent corporate achievements that position the Company to further extend its leadership in precision medicine. He will also take questions from the audience following each presentation.
Investors attending either conference who would like to schedule a one-on-one meeting with Caris executives may do so by contacting their representatives at Stifel or Canaccord Genuity Group, respectively.